Tin tức & Cập nhật
Xem bài viết Đa khoa
Xem
Fremanezumab helps prevent episodic migraine in youths
The use of fremanezumab is safe and effective for the prevention of episodic migraine (EM) in children and adolescents as young as 6 years old, according to a study presented at AAN 2025.
Fremanezumab helps prevent episodic migraine in youths
21 Apr 2025
Tolebrutinib reduces disability accumulation in relapsing MS
Treatment with tolebrutinib results in a clear reduction in disability accumulation in patients with relapsing multiple sclerosis (MS) compared with teriflunomide despite no difference in relapses, according to the findings of the GEMINI 1 and 2 trials presented at AAN 2025.
Tolebrutinib reduces disability accumulation in relapsing MS
21 Apr 2025
Is catheter ablation safe for treatment of ventricular arrhythmias in early phase after ACS?
Catheter ablation appears to be an effective procedure for patients with ventricular arrhythmias in the early phase following acute coronary syndrome (ACS), as shown by a study presented at EHRA 2025.
Is catheter ablation safe for treatment of ventricular arrhythmias in early phase after ACS?
20 Apr 2025
Consistent benefits with lecanemab seen in Clarity AD Asian cohort
In the treatment of early Alzheimer’s disease (AD), lecanemab is as safe and efficacious in Asian patients as in the wider Clarity AD population, slowing cognitive decline and reducing amyloid levels in the brain with manageable risks.
